Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19
NCT04910230
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Lymphopenia
Interventions
DRUG:
nicotinamide
Sponsor
Qiang Hu